SCHIPS, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 1.590
AS - Asia 1.247
EU - Europa 529
Continente sconosciuto - Info sul continente non disponibili 245
SA - Sud America 241
AF - Africa 48
OC - Oceania 3
Totale 3.903
Nazione #
US - Stati Uniti d'America 1.473
BD - Bangladesh 489
IT - Italia 465
CN - Cina 252
SG - Singapore 208
BR - Brasile 142
HK - Hong Kong 70
VN - Vietnam 50
IN - India 41
AR - Argentina 38
CA - Canada 37
MX - Messico 32
SA - Arabia Saudita 21
IQ - Iraq 18
ID - Indonesia 17
CO - Colombia 16
PH - Filippine 15
PE - Perù 13
JM - Giamaica 12
GB - Regno Unito 10
TR - Turchia 10
ZA - Sudafrica 10
CL - Cile 9
EC - Ecuador 9
ES - Italia 9
MA - Marocco 9
PK - Pakistan 9
CR - Costa Rica 8
TH - Thailandia 7
VE - Venezuela 7
MY - Malesia 6
NL - Olanda 6
UZ - Uzbekistan 6
EG - Egitto 5
GT - Guatemala 5
HN - Honduras 5
UA - Ucraina 5
BB - Barbados 4
DE - Germania 4
FR - Francia 4
PL - Polonia 4
RU - Federazione Russa 4
TN - Tunisia 4
BO - Bolivia 3
DZ - Algeria 3
GH - Ghana 3
KZ - Kazakistan 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
GE - Georgia 2
GR - Grecia 2
IL - Israele 2
JP - Giappone 2
KE - Kenya 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PY - Paraguay 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AL - Albania 1
AU - Australia 1
AW - Aruba 1
BE - Belgio 1
BF - Burkina Faso 1
BH - Bahrain 1
BY - Bielorussia 1
CM - Camerun 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GN - Guinea 1
IE - Irlanda 1
JO - Giordania 1
KR - Corea 1
KW - Kuwait 1
KY - Cayman, isole 1
LB - Libano 1
LR - Liberia 1
LT - Lituania 1
ML - Mali 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SR - Suriname 1
SX - ???statistics.table.value.countryCode.SX??? 1
Totale 3.655
Città #
San Jose 828
Ashburn 228
Beijing 113
Milan 99
Singapore 77
Hong Kong 70
Santa Clara 60
Figino 45
New York 45
Rome 42
Los Angeles 33
Buffalo 24
Mexico City 19
Ho Chi Minh City 18
Naples 18
Bologna 16
Dallas 14
Hanoi 12
Toronto 12
Turin 12
Genoa 11
Lima 11
Bari 10
Kingston 9
Florence 8
São Paulo 8
Brescia 7
Guayaquil 6
Palermo 6
Riyadh 6
Tashkent 6
Cape Town 5
Medina 5
Mumbai 5
Rio de Janeiro 5
Baghdad 4
Charlotte 4
Davao City 4
Guatemala City 4
Istanbul 4
Jakarta 4
Jeddah 4
Joinville 4
Medellín 4
Montreal 4
Orem 4
Padua 4
Porto Alegre 4
San Francisco 4
Seattle 4
Afragola 3
Atlanta 3
Bogotá 3
Bridgetown 3
Cairo 3
Chandigarh 3
Cincinnati 3
Da Nang 3
Dammam 3
Dartmouth 3
Delhi 3
Dhaka 3
Hyderabad 3
Hải Dương 3
Kuala Lumpur 3
La Paz 3
Livorno 3
Manila 3
Montoro 3
Ottawa 3
Phoenix 3
San José 3
Shanghai 3
Accra 2
Agadir 2
Amritsar 2
Ananindeua 2
Ancona 2
Athens 2
Baku 2
Barcelona 2
Barquisimeto 2
Bengaluru 2
Berazategui 2
Blumenau 2
Bolton 2
Boston 2
Brasília 2
Bắc Ninh 2
Cali 2
Carrollton 2
Casablanca 2
Catania 2
Chaguanas 2
Chennai 2
Chittagong 2
Columbus 2
Council Bluffs 2
Dakar 2
Damascus 2
Totale 2.076
Nome #
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database 435
Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation 77
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy 75
On-Clamp vs. Off-Clamp Robot-Assisted Partial Nephrectomy for cT2 Renal Tumors: Retrospective Propensity-Score-Matched Multicenter Outcome Analysis 60
Ultrasound prostate parameters as predictors of successful trial without catheter after acute urinary retention in patients ongoing medical treatment for benign prostatic hyperplasia: a prospective multicenter study 57
"Hair in the Bladder": An Unusual Finding 55
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis 51
Urological applications of N.O.T.E.S 45
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 36
Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma 35
Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis 34
Trifecta Outcomes of Partial Nephrectomy in Patients Over 75 Years Old: Analysis of the REnal SURGery in Elderly (RESURGE) Group 33
The R.E.N.A.L. nephrometric nomogram cannot accurately predict malignancy or aggressiveness of small renal masses amenable to partial nephrectomy 32
Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project) 31
Could Bladder Multiparametric MRI Be Introduced in Routine Clinical Practice? Role of the New VI-RADS Score: Results From a Prospective Study 30
Autologous fibrin glue using the Vivostat system for hemostasis in laparoscopic partial nephrectomy 29
Effects of Curcumin and Lactoferrin to Inhibit the Growth and Migration of Prostatic Cancer Cells 29
Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride? 28
Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the RECORd 2 project) 28
Comprehensive analysis of in-hospital delirium after major surgical oncology procedures 27
CD10 is a diagnostic and prognostic marker in renal malignancies 27
Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker 26
Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter "real life" study 26
Abiraterone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of ‘real-life’ studies 25
Current management of radiation cystitis after pelvic radiotherapy: a systematic review 25
Trends in the use of partial nephrectomy for cT1 renal tumors: Analysis of a 10-yr European multicenter dataset 25
The safety and feasibility of the simultaneous use of 180-W GreenLight laser for prostate vaporization during concomitant surgery 25
Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group) 25
New Anti-Androgen Compounds Compared to Docetaxel in Metastatic Hormone Sensitive Prostate Cancer: Results from a Network Meta-Analysis 25
Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group) 24
The use of polydimethylsiloxane in the treatment of incontinence after radical prostatectomy 24
Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy 24
The influence of ejaculation and abstinence on urinary flow rates 24
Abiraterone acetate for early stage metastatic prostate cancer: Patient selection and special considerations 23
Handicap of walking by a huge paratesticular liposarcoma 23
A fatal mycotic sepsis after retrograde intrarenal surgery: a case report and literature review 23
Neobladder "Function": Tips and Tricks for Surgery and Postoperative Management 23
Retroperitoneal extension of massive ulcerated testicular seminoma through the inguinal canal: A case report 23
Proposal for revision of the TNM classification system for renal cell carcinoma 22
Expanding indication for elective nephron-sparing surgery in renal cell carcinoma 22
Actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia: temporal trends of prescription and hospitalization rates over 5 years in a large population of Italian men 22
Conspicuity and muscle-invasiveness assessment for bladder cancer using VI-RADS: a multi-reader, contrast-free MRI study to determine optimal b-values for diffusion-weighted imaging 20
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium) 20
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis 20
Simultaneous robotic partial nephrectomy for bilateral renal masses 19
Urological laparoendoscopic single site surgery: multi-institutional analysis of risk factors for conversion and postoperative complications 19
Multiparametric Ultrasound Diagnostic Approach to Malignancy-Mimicking Adenomatoid Tumors of the Scrotum: Is Strain Elastography Enough? 19
Active surveillance for small renal masses in elderly patients does not increase overall mortality rates compared to primary intervention: a propensity score weighted analysis 19
Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma 19
Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era 18
Bladder Neck Contracture After Endoscopic Surgery for Benign Prostatic Obstruction: Incidence, Treatment, and Outcomes 18
Outcomes of Robot-assisted Partial Nephrectomy for Clinical T3a Renal Masses: A Multicenter Analysis 18
Operative profile, safety and functional outcomes after GreenLight laser prostate surgery: results from a 12 months follow-up multicenter Italian cohort analyses 18
GreenLight Photoselective Vaporization of the Prostate: One Laser for Different Prostate Sizes 18
Abiraterone Acetate for Treatment of Metastatic Castration-resistant Prostate Cancer in Chemotherapy-naive Patients: An Italian Analysis of Patients' Satisfaction 18
A comparison of hexaminolevulinate (Hexvix(®)) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study 18
Efficacy and safety of intravesical fibrin glue instillation for management of patients with refractory hemorrhagic cystitis: 12-months results. A promising therapy for hemorrhagic cystitis 17
Chatgpt vs traditional pedagogy: a comparative study in urological learning 17
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma 17
PI-RADS in Predicting csPCa: A Comparison Between Academic and Nonacademic Centers 17
Clinical effects and economical impact of dutasteride and finasteride therapy in Italian men with LUTS 17
Collecting duct renal cell carcinoma: a matched analysis of 41 cases 17
Do patients with a higher body mass index have a greater risk of advanced-stage renal cell carcinoma? 17
External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter database 17
MP08-03 PROGRESSION-FREE SURVIVAL AS SURROGATE ENDPOINT IN HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER STUDIES: RESULTS FROM A MACHINE LEARNING-BASED ANALYSIS OF A LARGE MULTI-INSTITUTIONAL DATABASE 17
Transperitoneal vs retroperitoneal minimally invasive partial nephrectomy: comparison of perioperative outcomes and functional follow-up in a large multi-institutional cohort (The RECORD 2 Project) 17
Intraoperative presentation of Bochdalek's hernia in an adult during robotic-assisted partial nephrectomy: An uncommon situation and literature review 17
RIRS in the elderly: Is it feasible and safe? 17
Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database 16
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicenter study 16
Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life study 16
Work up of incidental adrenal mass: state of the art 16
Management of local recurrence after radical nephrectomy: surgical removal with or without systemic treatment is still the gold standard. Results from a multicenter international cohort 16
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review 16
Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy 16
Monocenter Experience with 532 Nm-Laser Photoselective-Vaporization of the Prostate by GreenLight XPS Laser: Is It Really an Endourological Joker Card? 16
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors 16
Results of a comparative study analyzing octogenarians with renal cell carcinoma in a competing risk analysis with patients in the seventh decade of life 16
The Clinical Use of the Neutrophil to Lymphocyte Ratio (NLR) in Urothelial Cancer: A Systematic Review 16
Does overweight impact on the prognosis of patients with renal cell carcinoma? A single center experience of 683 patients 16
Predictors of the Transition from Off to On Clamp Approach during Ongoing Robotic Partial Nephrectomy: Data from the CLOCK Randomized Clinical Trial 15
Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation? 15
Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy 15
Mastering bladder paraganglioma for optimal treatment: a case report of robot-assisted surgery 15
CXCR4 and renal cancer: from lab to bedside 15
First Italian experience in single incision laparoscopic nephrectomy. Assessing and overcoming new challenges 15
Leydig cell tumor in a 53-year-old patient with gynecomastia and gynecodynia: A case report and literature review 14
How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency? 14
Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies 14
Persistence and adherence to androgen deprivation therapy in men with prostate cancer: an administrative database study 14
Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study 14
Efficacy and Safety of the 64Cu(II)Cl2 PET/CT for Urological Malignancies: Phase IIa Clinical Study 14
Laparo-Endoscopic Single-Site Left Transperitoneal Adrenalectomy 14
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 14
Assessing the accuracy and generalizability of the preoperative and postoperative Karakiewicz nomograms for renal cell carcinoma: results from a multicentre European and US study 14
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study 14
Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: A prospective multicenter Italian cohort study 14
Toward Individualized Approaches to Partial Nephrectomy: Assessing the Correlation Between Ischemia Time and Patient Health Status (RECORD2 Project) 14
Synergistic effects of curcumin and lactoferrin to inhibit the prostatic cancer cells growth and migration ability 14
Onabotulinumtoxin-A improves health status and urinary symptoms in subjects with refractory overactive bladder: Real-life experience 14
Totale 2.696
Categoria #
all - tutte 16.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.553


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20258 0 0 0 1 0 0 1 1 1 1 1 2
2025/20263.220 2 0 0 221 108 65 214 231 1.125 278 602 374
2026/2027675 157 518 0 0 0 0 0 0 0 0 0 0
Totale 3.903